Jill M. Broadfoot
2010 - Vical
In 2010, Jill M. Broadfoot earned a total compensation of $863.8K as Senior Vice President, Chief Financial Officer and Secretary at Vical, a 58% increase compared to previous year.
Compensation breakdown
| Bonus | $120,000 |
|---|---|
| Option Awards | $275,159 |
| Salary | $295,000 |
| Stock Awards | $173,000 |
| Other | $661 |
| Total | $863,820 |
Broadfoot received $295K in salary, accounting for 34% of the total pay in 2010.
Broadfoot also received $120K in bonus, $275.2K in option awards, $173K in stock awards and $661 in other compensation.
Rankings
In 2010, Jill M. Broadfoot's compensation ranked 5,854th out of 10,439 executives tracked by ExecPay. In other words, Broadfoot earned more than 43.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,854 out of 10,439 | 44th |
Division Manufacturing | 2,124 out of 3,838 | 45th |
Major group Chemicals And Allied Products | 462 out of 921 | 50th |
Industry group Drugs | 279 out of 680 | 59th |
Industry Biological Products, Except Diagnostic Substances | 57 out of 142 | 60th |
Source: SEC filing on April 10, 2013.
Broadfoot's colleagues
We found two more compensation records of executives who worked with Jill M. Broadfoot at Vical in 2010.
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019